{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T13:08:11Z","timestamp":1773148091034,"version":"3.50.1"},"reference-count":33,"publisher":"The Endocrine Society","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[1998,9,1]]},"abstract":"<jats:p>Recent studies suggest that fracture risk is associated with increased undercarboxylated osteocalcin. Methods use differences in binding of undercarboxylated and fully carboxylated osteocalcin to hydroxyapatite or barium sulfate. We evaluated these methods and found that results varied with the amount and preparation of the salts. Furthermore, patient samples with differing amounts of total osteocalcin could not be directly compared. Errors in the determination of undercarboxylated osteocalcin were minimized by expressing data as the percent of the total osteocalcin in the sample, and correcting for the basal level of osteocalcin using a polynomial equation derived from multiple binding curves. Errors from 5\u201315% in estimation of undercarboxylated osteocalcin were observed without both of these corrections. When differing types of assays were employed (RIA, intact, N-terminal), results also were affected. In normal adults and children and in patients on long-term warfarin therapy, the percent osteocalcin not bound to hydroxyapatite was lower when measured with an intact assay than by a polyclonal RIA. Differences were related to the amount of N-terminal osteocalcin fragments, which had low affinity for hydroxyapatite and resulted in variable overestimation of undercarboxylated osteocalcin.<\/jats:p><jats:p>In a kit specific for uncarboxylated osteocalcin, we found good discrimination between carboxylated and uncarboxylated intact osteocalcin. However, the assay detected large osteocalcin fragments and overestimated their concentration by up to 350%. Values for uncarboxylated osteocalcin were not different in patients on coumadin compared with normal adults with this kit, but when normalized to the total intact osteocalcin, percent uncarboxylated osteocalcin was greater in patients on coumadin than in controls, as would be expected. Kit values for uncarboxylated osteocalcin in normal children were higher than intact values in the same subject, because of the increased reactivity of the kit toward circulating fragments that were elevated in children.<\/jats:p><jats:p>Thus, for estimation of undercarboxylated osteocalcin, care must be taken to standardize the hydroxyapatite or barium sulfite used for binding, to correct for the basal level of osteocalcin in the sample, to use immunoassays that do not detect small fragments, and to express the results as the percent of the total osteocalcin in the sample. Without these precautions, the assessment of undercarboxylated osteocalcin is not reliable.<\/jats:p>","DOI":"10.1210\/jcem.83.9.5126","type":"journal-article","created":{"date-parts":[[2014,1,8]],"date-time":"2014-01-08T17:03:29Z","timestamp":1389200609000},"page":"3258-3266","source":"Crossref","is-referenced-by-count":15,"title":["Vitamin K Status and Bone Health: An Analysis of Methods for Determination of Undercarboxylated Osteocalcin1"],"prefix":"10.1210","volume":"83","author":[{"given":"Caren M.","family":"Gundberg","sequence":"first","affiliation":[{"name":"Department of Orthopaedics and Rehabilitation (C.M.G., S.D.N.), Yale University School of Medicine, New Haven, Connecticut 06510;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sherril D.","family":"Nieman","sequence":"additional","affiliation":[{"name":"Department of Orthopaedics and Rehabilitation (C.M.G., S.D.N.), Yale University School of Medicine, New Haven, Connecticut 06510;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven","family":"Abrams","sequence":"additional","affiliation":[{"name":"Department of Pediatrics (S.A.), Children\u2019s Nutrition Research Center, Baylor College of Medicine, Houston, Texas 77030;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harold","family":"Rosen","sequence":"additional","affiliation":[{"name":"Department of Geriatrics (H.R.), Beth Israel Deaconess Medical Center, Boston, Massachusetts 02115"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"80","reference":[{"key":"2020071620003014500_R1","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1146\/annurev.bi.46.070177.001105","article-title":"Vitamin K-dependent formation of gamma-carboxyglutamic acid.","volume":"46","author":"Stenflo","year":"1977","journal-title":"Annu Rev Biochem"},{"key":"2020071620003014500_R2","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/8756-3282(91)90027-G","article-title":"Depressed levels of circulating menaquinones in patients with osteoporotic fractures of the spine and femoral neck.","volume":"12","author":"Hodges","year":"1991","journal-title":"Bone"},{"key":"2020071620003014500_R3","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/0002-9343(93)90121-5","article-title":"Vitamin K and maintenance of skeletal integrity in adults.","volume":"94","author":"Rosen","year":"1993","journal-title":"Am J Med"},{"key":"2020071620003014500_R4","first-page":"249","article-title":"Bone mineral density in patients given oral vitamin K antagonists.","volume":"64","author":"Lafforque","year":"1997","journal-title":"Revue du Rhumatisme"},{"key":"2020071620003014500_R5","first-page":"635","article-title":"Decreased axial and peripheral bone density in patients taking long-term warfarin.","volume":"88","author":"Philip","year":"1995","journal-title":"Q J Med"},{"key":"2020071620003014500_R6","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/0140-6736(91)91292-3","article-title":"Heparins, coumarin, and bone density.","volume":"338","author":"Monreal","year":"1995","journal-title":"Lancet"},{"key":"2020071620003014500_R7"},{"key":"2020071620003014500_R8","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1093\/ajcn\/63.4.566","article-title":"Comparison of biochemical indexes for assessing vitamin K nutritional status in a healthy adult population.","volume":"63","author":"Sokoll","year":"1996","journal-title":"Am J Clin Nutr"},{"key":"2020071620003014500_R9","doi-asserted-by":"crossref","first-page":"12760","DOI":"10.1016\/S0021-9258(18)42960-2","article-title":"Origin of the vitamin K-dependent bone protein found in plasma and its clearance by kidney and bone.","volume":"256","author":"Price","year":"1981","journal-title":"J Biol Chem"},{"key":"2020071620003014500_R10","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1093\/clinchem\/41.8.1121","article-title":"Undercarboxylated osteocalcin: development of a method to determine vitamin K status.","volume":"41","author":"Sokoll","year":"1995","journal-title":"Clin Chem"},{"key":"2020071620003014500_R11","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1172\/JCI116387","article-title":"Serum undercarboxylated osteocalcin is a marker of the risk of hip fracture in elderly women.","volume":"91","author":"Szulc","year":"1993","journal-title":"J Clin Invest"},{"key":"2020071620003014500_R12","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1002\/jbmr.5650091012","article-title":"Serum undercarboxylated osteocalcin correlates with hip bone mineral density in elderly women.","volume":"9","author":"Szulc","year":"1994","journal-title":"J Bone Miner Res"},{"key":"2020071620003014500_R13","first-page":"719","article-title":"Undercarboxylated osteocalcin measured with a specific immunoassy predicts hip fracture in elderly women: the EPIDOS study.","volume":"82","author":"Vergnaud","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071620003014500_R14","author":"Gundberg","year":"1984"},{"key":"2020071620003014500_R15","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1359\/jbmr.1997.12.3.447","article-title":"Identification of peptide fragments generated by digestion of bovine and human osteocalcin with the lysosomal proteinases cathepsin B, D, L, H, and S.","volume":"12","author":"Baumgrass","year":"1997","journal-title":"J Bone Miner Res"},{"key":"2020071620003014500_R16","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/256495a0","article-title":"Continuous cultures of fused cells secreting antibody of defined specificity.","volume":"256","author":"Kohler","year":"1975","journal-title":"Nature"},{"key":"2020071620003014500_R17","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1093\/clinchem\/35.7.1408","article-title":"Radioimmunoassay of osteocalcin with polyclonal and monoclonal antibodies.","volume":"35","author":"Power","year":"1989","journal-title":"Clin Chem"},{"key":"2020071620003014500_R18"},{"key":"2020071620003014500_R19","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1093\/clinchem\/40.11.2071","article-title":"Six osteocalcin assays compared.","volume":"40","author":"Diego","year":"1994","journal-title":"Clin Chem"},{"key":"2020071620003014500_R20","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1172\/JCI112499","article-title":"Multiple immunoreactive forms of osteocalcin in uremic serum.","volume":"77","author":"Gundberg","year":"1986","journal-title":"J Clin Invest"},{"key":"2020071620003014500_R21","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1093\/clinchem\/41.2.318","article-title":"Apparent instability of osteocalcin in serum as measured with different commercially available immunoassays.","volume":"41","author":"Blumsohn","year":"1995","journal-title":"Clin Chem"},{"key":"2020071620003014500_R22","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/8756-3282(95)00133-X","article-title":"Carboxylation of osteocalcin in post-menopausal osteoporotic women following vitamin K and D supplementation.","volume":"17","author":"Douglas","year":"1995","journal-title":"Bone"},{"key":"2020071620003014500_R23","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/0169-6009(90)90062-K","article-title":"Normal carboxylation of circulating osteocalcin (bone Gla-protein) in Paget\u2019s disease of bone.","volume":"11","author":"Merle","year":"1990","journal-title":"Bone Miner"},{"key":"2020071620003014500_R24","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1002\/jbmr.5650091220","article-title":"Direct demonstration that the vitamin K-dependent bone Gla protein is incompletely g-carboxylated in humans.","volume":"9","author":"Cairns","year":"1994","journal-title":"J Bone Miner Res"},{"key":"2020071620003014500_R25","first-page":"171","article-title":"Synthesis of human osteocalcins: gamma-carboxyglutamic acid at position 17 is essential for a calcium-dependent conformational transition.","volume":"7","author":"Nakao","year":"1994","journal-title":"Pept Res"},{"key":"2020071620003014500_R26","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1002\/ar.1092240208","article-title":"Osteocalcin-hydroxyapatite interaction in the extracellular organic matrix of bone.","volume":"224","author":"Hauschka","year":"1989","journal-title":"Anat Rec"},{"key":"2020071620003014500_R27","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1002\/jbmr.5650090215","article-title":"Characterization of immunoreactive forms of human osteocalcin generated in vivo and in vitro.","volume":"9","author":"Garnero","year":"1994","journal-title":"J Bone Miner Res"},{"key":"2020071620003014500_R28","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1002\/jbmr.5650111123","article-title":"Serum N-terminal osteocalcin is a good indicator for estimating responders to hormone replacement therapy in postmenopausal women.","volume":"11","author":"Chen","year":"1996","journal-title":"J Bone Miner Res"},{"key":"2020071620003014500_R29"},{"key":"2020071620003014500_R30","first-page":"333","article-title":"Molecular basis and clinical application of biological markers of bone turnover.","volume":"17","author":"Calvo","year":"1996","journal-title":"Endocr Rev"},{"key":"2020071620003014500_R31","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1002\/jbmr.5650110307","article-title":"Increased bone turnover in late postmenopausal women is a major determinant of osteoporosis.","volume":"11","author":"Garnero","year":"1996","journal-title":"J Bone Miner Res"},{"key":"2020071620003014500_R32","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1002\/jbmr.5650061111","article-title":"Impairment of gamma carboxylation of circulating osteocalcin (Bone Gla Protein) in elderly women.","volume":"6","author":"Plantalech","year":"1991","journal-title":"J Bone Miner Res"},{"key":"2020071620003014500_R33","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/8756-3282(96)00037-3","article-title":"Serum undercarboxylated osteocalcin is a marker of the risk of hip fracture: a three year follow-up study.","volume":"18","author":"Szulc","year":"1996","journal-title":"Bone"}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/83\/9\/3258\/9230839\/jcem3258.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/83\/9\/3258\/9230839\/jcem3258.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,21]],"date-time":"2022-03-21T23:52:56Z","timestamp":1647906776000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/83\/9\/3258\/2865540"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,9,1]]},"references-count":33,"journal-issue":{"issue":"9","published-print":{"date-parts":[[1998,9,1]]}},"URL":"https:\/\/doi.org\/10.1210\/jcem.83.9.5126","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published":{"date-parts":[[1998,9,1]]}}}